Investor.regeneron.com

FDA Expands Authorized Use of REGEN-COV™ (casirivimab and …

WebTARRYTOWN, N.Y. , July 30, 2021 /PRNewswire/ -- Expanded authorization enables use of REGEN-COV for post-exposure prophylaxis in certain people exposed to a SARS-CoV-2 …

Actived: Just Now

URL: https://investor.regeneron.com/news-releases/news-release-details/fda-expands-authorized-use-regen-covtm-casirivimab-and-imdevimab

INVESTORS & MEDIA

WebTARRYTOWN, N.Y. , June 4, 2021 /PRNewswire/ -- EUA supported by pivotal Phase 3 data showing 1,200 mg dose reduced risk of hospitalization or death by 70% Only antibody …

Category: Health Go Health

INVESTORS & MEDIA

WebTARRYTOWN, N.Y., Sept. 14, 2021 /PRNewswire/ -- New agreement for 1.4 million doses of REGEN-COV, brings total purchased by the U.S. government to nearly 3 million …

Category: Health Go Health

FDA Approves Dupixent® (dupilumab) as First Treatment for …

WebTARRYTOWN, N.Y. and PARIS, May 20, 2022 /PRNewswire/ -- Dupixent is the first and only medicine indicated to treat eosinophilic esophagitis in the United States; …

Category: Medicine Go Health

INVESTORS & MEDIA

WebRegeneron Contacts: Media Relations Sharon Chen Tel: +1 914-847-1546 [email protected]: Investor Relations Vesna Tosic Tel: +1 914-847-5443 …

Category: Health Go Health

Regeneron Announces Formation of Regeneron Cell Medicines …

WebRegeneron to assume full development and commercialization rights for 2seventy bio’s preclinical and clinical stage cell therapy pipeline. TARRYTOWN, N.Y., …

Category: Health Go Health

INVESTORS & MEDIA

WebTARRYTOWN, N.Y., July 1, 2021 /PRNewswire/ -- Publication in Science reports that people with these protective mutations have 54% reduced risk of obesity. Regeneron …

Category: Health Go Health

J.P.Morgan Healthcare Conference

Web100% of Medicare jurisdictions have confirmed paid claims. Remain on track for permanent J-Code. on April 1, 2024. Dupixent global net product sales grew 34% and …

Category: Health Go Health

Dupixent® (dupilumab) FDA Approved as First and Only …

WebApproval based on Phase 3 EoE KIDS trial showing a greater proportion of children taking Dupixent achieved histological remission compared to placebo Expanded …

Category: Health Go Health

Regeneron and Sanofi Announce Positive Phase 2 Study …

Webinvestigational medicines being developed for the treatment of rare diseases or conditions that affect fewer than 200,000 people in the United States .

Category: Medicine Go Health

Regeneron Genetics Center Discovers Rare Mutations In The …

WebNew research published in The New England Journal of Medicine reveals that people with certain genetic loss-of-function mutations have more than 50% lower risk of nonalcoholic …

Category: Medicine Go Health

Praluent® (alirocumab) Injection Receives FDA Approval to Treat

WebApproval extends treatment of Praluent to children aged 8 and older with heterozygous familial hypercholesterolemia (HeFH) TARRYTOWN, N.Y., March 11, …

Category: Health Go Health

FDA Approves Dupixent® (dupilumab) for Chronic …

Web52% and 45% improvement in loss of smell compared to a 12% and 10% improvement for placebo in SINUS-24 and SINUS-52, respectively (LS mean difference in Dupixent …

Category: Health Go Health

INVESTORS & MEDIA

WebTARRYTOWN, N.Y. and PARSIPPANY, N.J., June 6, 2018 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Zoetis Inc. (NYSE:ZTS) today announced a …

Category: Health Go Health

Oppenheimer 34th Annual Healthcare Life Sciences Conference

WebOppenheimer 34th Annual Healthcare Life Sciences Conference. Feb 14 1:20 PM EST. Listen to the Oppenheimer 34th Annual Healthcare Life Sciences …

Category: Health Go Health

INVESTORS & MEDIA

WebTARRYTOWN, N.Y., March 24, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer will jointly develop a combination therapy of the …

Category: Health Go Health

Regeneron and Geisinger Health System Announce Major Human …

WebTARRYTOWN, N.Y., Jan. 13, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Geisinger Health System (Geisinger), one of the largest …

Category: Health Go Health

Regeneron and Sanofi Announce 18-Month Results of …

WebPraluent is an investigational fully human monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). Earlier this year,

Category: Health Go Health

Dupixent® (dupilumab) U.S. Label Updated with Data Further …

WebData included from first and only Phase 3 trial specifically evaluating a biologic in this difficult-to-treat population Phase 3 trial showed more than twice as many …

Category: Health Go Health

Sanofi and Regeneron Announce Publication of Positive Phase …

Webfor the initiation and maintenance of this Th2 immune response.€ IL-4 and IL-13 signaling occurs through Type I and II IL-4 receptors (IL-4 through both receptors and IL-13 …

Category: Health Go Health

Together for CHANGE Genomics and Equity Initiative Launched by …

WebNIH data show that globally less than 2% of genetic information being studied today originates from people of African ancestry 1. The newly established Diaspora …

Category: Health Go Health

Regeneron builds on Together for CHANGE™ initiative with five …

WebCommitment builds on Regeneron’s longstanding efforts to develop the STEM talent pipeline as lead sponsor of the premier high school competitions, the …

Category: Health Go Health

Top Categories

› Appendicitis

› Gout

› Women's Health

› Thyroid

› Sleep

› Skin

› Sexual Health

› Senior Health

› Oral Health

› Mental Health

› Men's Health

› Medications

› Lung Conditions

› Infectious Disease

Popular Searched

› Aarp united healthcare replace insurance card

› Fnb health cash plan benefits

› Designated health services list

› Health insurance options exchange

› Mcr health manatee locations

› 30 day gut health tracker

› Pih health aep guide

› Pih health aetna insurance

› Pih health medicare supplement plans

› Pih health optometry plans

Recently Searched

› Top 100 health insurance companies

› Trinity health 403b plan

› Powell county health department facebook

› Health department orange city

› Statistics on teens mental health

› Osha health and safety manual 2023

› Northern health patient information request

› Health care project management methods

› Pla behavioral health in indiana

› Healthspring prior authorization fax form

The medical information found on the MedUSafe website is designed to support, not to replace the relationship between patient and physician and the medical advice they may provide.